Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Making care fit manifesto.
Kunneman M, Griffioen IPM, Labrie NHM, Kristiansen M, Montori VM, van Beusekom MM; Making Care Fit Working Group. Kunneman M, et al. BMJ Evid Based Med. 2023 Feb;28(1):5-6. doi: 10.1136/bmjebm-2021-111871. Epub 2021 Nov 23. BMJ Evid Based Med. 2023. PMID: 34815303 Free PMC article. No abstract available.
Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX - The LAPC-2 trial.
van 't Land FR, Latifi D, Moskie M, Homs MYV, Bosscha K, Bonsing BA, Mieog SD, van der Harst E, Coene PLO, Wijsman JH, van der Schelling GP, Groot Koerkamp B, Nuyttens JJ, van Eijck CHJ; South West Pancreatic Cancer Care SWPCC consortium. van 't Land FR, et al. Among authors: moskie m. Radiother Oncol. 2023 Jun;183:109541. doi: 10.1016/j.radonc.2023.109541. Epub 2023 Feb 20. Radiother Oncol. 2023. PMID: 36813171 Clinical Trial.
A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma.
van Eijck CWF, de Koning W, van der Sijde F, Moskie M, Groot Koerkamp B, Homs MYV, van der Burg SH, van Eijck CHJ, Mustafa DAM. van Eijck CWF, et al. Among authors: moskie m. Eur J Cancer. 2023 Mar;181:119-134. doi: 10.1016/j.ejca.2022.12.024. Epub 2022 Dec 28. Eur J Cancer. 2023. PMID: 36652890 Free article.
Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program.
El Haddaoui H, Brood R, Latifi D, Oostvogels AA, Klaver Y, Moskie M, Mustafa DA, Debets R, van Eijck CHJ. El Haddaoui H, et al. Among authors: moskie m. Cancers (Basel). 2022 Mar 8;14(6):1377. doi: 10.3390/cancers14061377. Cancers (Basel). 2022. PMID: 35326528 Free PMC article.